These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15181321)

  • 1. Selenium in the treatment of head and neck lymphedema.
    Bruns F; Büntzel J; Mücke R; Schönekaes K; Kisters K; Micke O
    Med Princ Pract; 2004; 13(4):185-90. PubMed ID: 15181321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium in the treatment of radiation-associated secondary lymphedema.
    Micke O; Bruns F; Mücke R; Schäfer U; Glatzel M; DeVries AF; Schönekaes K; Kisters K; Büntzel J
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):40-9. PubMed ID: 12694822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium substitution during radiotherapy of solid tumours - laboratory data from two observation studies in gynaecological and head and neck cancer patients.
    Büntzel J; Micke O; Kisters K; Bruns F; Glatzel M; Schönekaes K; Kundt G; Schäfer U; Mücke R
    Anticancer Res; 2010 May; 30(5):1783-6. PubMed ID: 20592379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of postoperative lymphedema after oral tumor surgery with sodium selenite.
    Zimmermann T; Leonhardt H; Kersting S; Albrecht S; Range U; Eckelt U
    Biol Trace Elem Res; 2005 Sep; 106(3):193-203. PubMed ID: 16141467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients.
    Büntzel J; Riesenbeck D; Glatzel M; Berndt-Skorka R; Riedel T; Mücke R; Kisters K; Schönekaes KG; Schäfer U; Bruns F; Micke O
    Anticancer Res; 2010 May; 30(5):1829-32. PubMed ID: 20592387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium selenite as prophylaxis against erysipelas in secondary lymphedema.
    Kasseroller R
    Anticancer Res; 1998; 18(3C):2227-30. PubMed ID: 9703790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
    Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of secondary lymphedema in patients with head and neck cancer.
    Deng J; Ridner SH; Dietrich MS; Wells N; Wallston KA; Sinard RJ; Cmelak AJ; Murphy BA
    J Pain Symptom Manage; 2012 Feb; 43(2):244-52. PubMed ID: 21802897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
    Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
    J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal fentanyl for pain caused by radiotherapy in head and neck cancer patients treated in an outpatient setting: a multicenter trial in Taiwan.
    Chang JT; Lin CY; Lin JC; Lee MS; Chen YJ; Wang HM
    Jpn J Clin Oncol; 2010 Apr; 40(4):307-12. PubMed ID: 20042478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
    Brizel DM; Albers ME; Fisher SR; Scher RL; Richtsmeier WJ; Hars V; George SL; Huang AT; Prosnitz LR
    N Engl J Med; 1998 Jun; 338(25):1798-804. PubMed ID: 9632446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium selenite and cancer related lymphedema: Biological and pharmacological effects.
    Pfister C; Dawzcynski H; Schingale FJ
    J Trace Elem Med Biol; 2016 Sep; 37():111-116. PubMed ID: 27267968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium Selenite Alleviates Breast Cancer-Related Lymphedema Independent of Antioxidant Defense System.
    Han HW; Yang EJ; Lee SM
    Nutrients; 2019 May; 11(5):. PubMed ID: 31067718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy.
    Allal AS; Nicoucar K; Mach N; Dulguerov P
    Head Neck; 2003 Oct; 25(10):833-9; discussion 839-40. PubMed ID: 12966507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
    Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term quality of life of patients with head and neck cancer.
    de Graeff A; de Leeuw JR; Ros WJ; Hordijk GJ; Blijham GH; Winnubst JA
    Laryngoscope; 2000 Jan; 110(1):98-106. PubMed ID: 10646723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.